{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:17:34Z","timestamp":1791393454784,"version":"4.3.3"},"reference-count":75,"publisher":"Baishideng Publishing Group Inc.","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJH"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4254\/wjh.v7.i11.1450","type":"journal-article","created":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T07:50:21Z","timestamp":1433749821000},"page":"1450","source":"Crossref","is-referenced-by-count":159,"title":["Non-alcoholic fatty liver disease in 2015"],"prefix":"10.4254","volume":"7","author":[{"given":"Monjur","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws448"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.39"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12011"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04724.x"},{"key":"ref5","unstructured":"Fan JG, Peng YD. Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat Dis Int 2007;6:572-578."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1204265"},{"key":"ref7","unstructured":"King MW. Introduction to Insulin Activities. 1996-2013 Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/themedicalbiochemistrypage.org\/insulin.php\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/themedicalbiochemistrypage.org\/insulin.php<\/ext-link>."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.7.8736"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15057352"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.07.057"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-013-1294-3"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1089\/met.2012.0064"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-860864"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.03.020"},{"key":"ref15","unstructured":"Bayard M, Holt J, Boroughs E. Nonalcoholic fatty liver disease. Am Fam Physician 2006;73:1961-1968."},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745-750.","DOI":"10.1053\/gast.2002.35354"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.05.023"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.171.3.9725292"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80228-6"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.22580"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05121.x"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i42.5286"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1586\/egh.11.21"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.01.026"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21103"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.10.027"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01377.x"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102153440706"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.883601"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21496"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.05.033"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Borsoi Viana MS, Takei K, Collarile Yamaguti DC, Guz B, Strauss E. Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C. Ann Hepatol 2009;8:26-31.","DOI":"10.1016\/S1665-2681(19)31807-1"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Loaeza-del-Castillo A, Paz-Pineda F, Oviedo-C&aacute;rdenas E, S&aacute;nchez-Avila F, Vargas-Vor&aacute;ckov&aacute; F. AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis. Ann Hepatol 2008;7:350-357.","DOI":"10.1016\/S1665-2681(19)31836-8"},{"key":"ref34","unstructured":"Afdhal NH. Fibroscan (transient elastography) for the measurement of liver fibrosis. Gastroenterol Hepatol (NY) 2012;8:605-607."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181e12c39"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.77a.09138"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Rustogi R, Horowitz J, Harmath C, Wang Y, Chalian H, Ganger DR, Chen ZE, Bolster BD, Shah S, Miller FH. Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging 2012;35:1356-1364.","DOI":"10.1002\/jmri.23585"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.112094"},{"key":"ref39","unstructured":"Tilg H, Moschen A. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease. Minerva Gastroenterol Dietol 2010;56:159-167."},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.02.011"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/nu5082901"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3109\/13880209.2011.604088"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9145-x"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25762"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907929"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1013127"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X09105462"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1177\/2042018810379587"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2008.09.003"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.09.025"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23727"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20092"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24544"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Van Wagner LB, Koppe SW, Brunt EM, Gottstein J, Gardikiotes K, Green RM, Rinella ME. Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial. Ann Hepatol 2013;10:277-286.","DOI":"10.1016\/S1665-2681(19)31539-X"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-012-0305-5"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X104696"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i41.5839"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.02.004"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22575"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2006.01315.x"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21006"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Balaban YH, Korkusuz P, Simsek H, Gokcan H, Gedikoglu G, Pinar A, Hascelik G, Asan E, Hamaloglu E, Tatar G. Dipeptidyl peptidase IV (DDP IV) in NASH patients. Ann Hepatol 2007;6:242-250.","DOI":"10.1016\/S1665-2681(19)31905-2"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.5754\/hge11263"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1159\/000341510"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1586\/egh.11.97"},{"key":"ref66","unstructured":"Grimm IS, Schindler W, Haluszka O. Steatohepatitis and fatal hepatic failure after biliopancreatic diversion. Am J Gastroenterol 1992;87:775-779."},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2012.10.525"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.881749"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2013.08.036"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1038\/nm0511-552"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840140635"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(13)61319-7"},{"key":"ref73","unstructured":"Gilead Sciences. Safety and Efficacy of Simtuzumab (GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.clinicaltrials.gov\/show\/NCT01672866 NLM Identifier: NCT01672866\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.clinicaltrials.gov\/show\/NCT01672866 NLM Identifier: NCT01672866<\/ext-link>."},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d6891"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(14)63307-2"}],"container-title":["World Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v7\/i11\/1450.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T10:17:24Z","timestamp":1566814644000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v7\/i11\/1450.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":75,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.4254\/wjh.v7.i11.1450","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}